Department of Internal Medicine III - Oncology
Professor Dr. Dr. Michael von Bergwelt |
Staff: |
|
|
Medical Service
(financed by third-party funds): |
76
(7)
|
|
Medical-Technical Service
(financed by third-party funds): |
120
(57)
|
|
|
| Number of inpatient cases: |
3.735 |
Services of the Department of Internal Medicine III (Oncology):
Curriculum Vitae of Professor Dr. Dr. Michael von Bergwelt
Training and Degrees
|
1988- 1996
|
Studies of Medicine at the universities of Freiburg and Paris
|
|
1994- 1996
|
Studies of Human Biology at Université Paris Sud
|
|
1996
|
Approbation in Medicine; Maîtrise de Sciences Biologiques et Médicales (MSBM); United States Medical License Examination (USMLE) Parts I/II
|
|
1997-1999
|
Internship, Department I of Internal Medicine (University of Cologne)
|
|
1997
|
Dissertation (Dr. med.) „Phenotypical and functional characterization of tumor infiltrating lymphocytes in colorectal carcinoma under stimulation with Interleukin-2 and Interleukin-4 in vitro” (Albert-Ludwigs-University of Freiburg)
|
|
1999-2002
|
PostDoc, Dana-Farber Cancer Institute (Harvard Medical School, Boston, USA)
|
|
1999
|
Board Certification in Emergency Medicine (Lower Saxony)
|
|
2002-2007
|
Internship and Fellowship at the Department I of Internal Medicine (University of Cologne, Director Prof. M. Hallek)
|
|
2002
|
Dissertation (Dr. rer. nat.) “Biological and Biotechnological Analyses on CD40-activated B cells as Antigen Presenting Cells” (University of Oldenburg)
|
|
2003- 2009
|
Head of Max-Eder Junior Research Group, German Cancer Aid
|
|
2006
|
Board Certification in Internal Medicine, Hematology and Oncology
|
|
2007
|
Consultant at the Department I of Internal Medicine, University of Cologne (Director Prof. M. Hallek); Venia Legendi in Internal Medicine: „Analysis of the antigen presenting function of B cells: translation to tumor immunotherapy”
|
|
2008
|
Board Certification in Intensive Care Medicine; Director of Cologne Interventional Immunology; Scientific Director SCT-Program of the Department I of Internal Medicine (University of Cologne, Director Prof. M. Hallek);
|
|
2009
|
Board Certification in Infectiology
|
|
2012
|
Adjunct Professor of Internal Medicine (University of Cologne)
|
|
2015
|
Head of clinical trial, CAR-Time Research Consortium (CAR T cells in Melanoma-clinical trial), Bundesministerium für Bildung und Forschung (BMBF)
|
|
2016
|
Adjunct Professor of Internal Medicine (University of Cologne)
|
|
since 2017
|
Full professor and Director of the Department of Internal Medicine III (Ludwig-Maximilians-University Munich, Germany)
|
|
|
Memberships, Prizes and Honors
|
1997
|
Mildred-Scheel-Fellow, German Cancer Aid (“Deutsche Krebshilfe”)
|
|
1999
|
Scientific Award of the European Medical Students´ Association (EMSA, University of Prague)
|
|
1999
|
Travel Award of the American Society of Hematology
|
|
2001
|
Member of Lymphoma Research Foundation of America
|
|
2002
|
Member of German José Carreras-Leukemia Foundation
|
|
2010
|
Basic Science Award of the European Society for Blood and Marrow Transplantation
|
|
2010
|
Travel Award of the American Society for Blood and Marrow Transplantation
|
|
2015
|
Best Abstract Award of DGHO (Co-author)
|
|
|
Publications
